LACTOBACILLUS BREVIS G-101 STRAIN AND USE THEREOF

• Main Authors: SHIN, GO-EUN, KIM, SE-YOUNG, KANG, YOON-MO, LEE, BYEONG-GON, JEON, HONG RYEOL
• Format: Patent
• Language: English; French; Korean
• Published: 11.12.2014
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS THEREOF; CULTURE MEDIA; ENZYMOLOGY; FOODS OR FOODSTUFFS; FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MICROORGANISMS OR ENZYMES; MUTATION OR GENETIC ENGINEERING; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; SPIRITS; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES; VINEGAR; WINE

The present invention relates to a novel Lactobacillus brevis G-101 strain capable of dissolving monosodium L-glutamate (MSG), and a functional health food, a pharmaceutical composition, or a food product containing the Lactobacillus G-101 strain as an active ingredient. More specifically, the strain is effective in reducing blood MSG levels in the body of animals and reducing MSG-related complex syndromes, and thus can be used in the functional health food, the pharmaceutical composition, or the food product aiming to prevent absorption of MSG, which is known to be harmful, in the body, and improving the MSG-related complex syndromes. La présente invention concerne une nouvelle souche de Lactobacillus brevis G-101 capable de dissoudre le L-glutamate monosodique (GMS), et un aliment naturel fonctionnel, une composition pharmaceutique ou un produit alimentaire contenant la souche de Lactobacillus G-101 souche en tant que principe actif. Plus spécifiquement, la souche est efficace dans la réduction des taux de GMS dans le corps d'animaux et la réduction de syndromes complexes liés au GMS, et peut ainsi être utilisée dans l'aliment naturel fonctionnel, la composition pharmaceutique ou le produit alimentaire visant à empêcher l'absorption du GMS qui est réputé être nocif, dans le corps, et atténuant les syndromes complexes liés au GMS.